AzTrials
AzTrials

Cardiac ArrestPREDOHCANCT06030986

Prediction of Outcome in Out-of-Hospital Cardiac Arrest

An observational study of Cardiac Arrest, run by Kepler University Hospital at 1 site in Austria.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

In the course of prehospital respiratory and circulatory arrest, approximately 1000 persons are resuscitated by cardiopulmonary resuscitation in Upper Austria every year. Despite constant further development of methods, equipment and continuous training of the rescue and emergency medical teams working on site, the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest
What is being tested?
ILCOR Utstein OHCA Core Outcome
How many people
10,000 participants
Where
1 siteAustria
Study dates
1 Dec 2025to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: As described in the inclusion criteria.

Who may be able to join

  • Patients 18 years or older AND
  • between 2015-01-01 and 2023-10-31 AND
  • have been treated by emergency medical teams of the Austrian Red Cross, District Branch of Upper Austria AND
  • have suffered out-of-hospital cardiac arrest AND
  • have been treated by emergency physicians while out of hospital AND
  • have been transported to the Kepler University Hospital, Linz, Austria

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Austria1 site
  • Kepler University Hospital

    Linz, Upper Austria, 4020

    Jens Meier, MD, +435768083 ext. 2158, jens.meier@kepleruniklinikum.at

    Thomas Tschoellitsch, MD, +435768083 ext. 78132, thomas.tschoellitsch@jku.at

Other trials in Austria

About this study

In the course of prehospital respiratory and circulatory arrest, approximately 1000 persons are resuscitated by cardiopulmonary resuscitation in Upper Austria every year. Despite constant further development of methods, equipment and continuous training of the rescue and emergency medical teams working on site, the majority of patients who have to be resuscitated prehospital still die. However, even patients whose circulatory function can be restored during prehospital resuscitation (Return of Spontaneous Circulation, ROSC) require intensive medical care for days to weeks and often find it very difficult to return to a normal, independent life.

The success of resuscitation measures depends on the quality of the resuscitation performed as well as on patient-specific factors. Evaluation scales such as the Cerebral Performance Category score (CPC) allow a posteriori assessment of resuscitation success. Nowadays, it is very difficult to estimate the outcome of resuscitation a priori. In many cases, it is not at all clear at the beginning of the treatment pathway whether the individual patient is expected to have an unfavorable prognosis in the context of respiratory arrest or whether a restitutio ad integrum is possible.

Read more

Thus, the decision to continue or discontinue resuscitation can only be made on the basis of an individual physician's assessment. In addition to the primary concern of stopping resuscitation too early, there is also the risk that medical resources are used beyond the normal level after resuscitation without expecting a successful outcome. Estimating and categorizing the subsequent outcome is difficult and emotionally stressful for the treating team in the acute situation. Some factors that influence outcome are now known: As cerebral hypoperfusion increases, the probability of survival decreases sharply with each passing minute. In this context, potentially reversible causes have been identified in different works, allowing causal therapy to improve neurological outcome. In addition to the most important therapy bridging hypoperfusion, chest compression, with the aim of ensuring minimal perfusion of the brain, immediate defibrillation should be mentioned in particular, which now allows medical laypersons to use defibrillators as part of the Public Access Defibrillation Network.

Despite all efforts, however, it is not yet possible to make reliable statements about the probable outcome of persons with respiratory and circulatory arrest with a high degree of certainty in a large number of cases at an early stage.

Artificial intelligence refers to the ability of machines to perform cognitive tasks, such as recognizing objects in images and classifying them. For a long time, many processes were too complex to explore through sufficient computing power, storage capacity, and understanding. More recently, however, technological advances have brought machine learning (ML) and the constructs behind it, including those based on so-called neural networks (known since about 1950), back to the fore. Not only the development of theoretical models, but after extensive testing also devices applicable in daily routine operation are available.

Modern machine learning methods are enabling a variety of new approaches to assessing operations, including modeling complex systems and finding relationships between models.

Conditions
Cardiac Arrest
Being tested
ILCOR Utstein OHCA Core Outcome
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ILCOR Utstein OHCA Core OutcomeDiagnostic test

    ILCOR Utstein OHCA Core Outcome

Study groups in NCT06030986
Study groupRoleWhat they receive
ILCOR Utstein OHCA Core Outcome PositiveRespectively for all core outcomes defined.
Receives: Diagnostic Test: ILCOR Utstein OHCA Core Outcome
ILCOR Utstein OHCA Core Outcome NegativeRespectively for all core outcomes defined.
Receives: Diagnostic Test: ILCOR Utstein OHCA Core Outcome

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome

    AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome

    Measured: 2015-01-01 - 2023-10-31

  2. AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome

    AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome

    Measured: 2015-01-01 - 2023-10-31

  3. F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome

    F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome

    Measured: 2015-01-01 - 2023-10-31

  4. Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome

    Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome

    Measured: 2015-01-01 to 2023-10-31

Secondary outcomes (4)
  1. AUC-ROC for Prediction of Diagnosis at Hospital Discharge

    AUC-ROC for Prediction of Diagnosis at Hospital Discharge

    Measured: 2015-01-01 - 2023-10-31

  2. AUC-PRC for Prediction of Diagnosis at Hospital Discharge

    AUC-PRC for Prediction of Diagnosis at Hospital Discharge

    Measured: 2015-01-01 - 2023-10-31

  3. F1-Score for Prediction of Diagnosis at Hospital Discharge

    F1-Score for Prediction of Diagnosis at Hospital Discharge

    Measured: 2015-01-01 - 2023-10-31

  4. Confusion Matrix for Prediction of Diagnosis at Hospital Discharge

    Confusion Matrix for Prediction of Diagnosis at Hospital Discharge

    Measured: 2015-01-01 - 2023-10-31

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2023
  2. Study start1 Dec 2025 (estimated)
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06030986
Sponsor's protocol ID
PREDOHCA
Acronym
PREDOHCA
Status last verified
Oct 2024
First submitted
3 Sep 2023
Last updated
3 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest, run by Kepler University Hospital at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Thomas Tschoellitsch, MD (+435768083 ext. 78132, thomas.tschoellitsch@jku.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome (time frame: 2015-01-01 - 2023-10-31). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in